Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 25 (4) , 707-714
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Drug and Gene Delivery to the BrainNeuron, 2002
- Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approachesNature Neuroscience, 2002
- Kinetic Analysis of the Disposition of Insulin-Like Growth Factor 1 in Healthy VolunteersPharmaceutical Research, 2001
- Circulating Insulin-Like Growth Factor I Mediates the Protective Effects of Physical Exercise against Brain Insults of Different Etiology and AnatomyThe Journal of Neuroscience, 2001
- Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticlesJournal of Controlled Release, 2001
- Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheresJournal of Controlled Release, 2001
- Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetesJournal of Controlled Release, 2000
- Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxiaProceedings of the National Academy of Sciences, 1998
- Continuous Versus Intermittent Subcutaneous Infusion of Octreotide in the Treatment of AcromegalyThe Journal of Clinical Pharmacology, 1995
- Aging as a major risk for degenerative diseases of the central nervous systemCurrent Opinion in Neurology, 1994